Sweden· SE-20250227000046
Holoxan 500 mg Pulver till injektions-/infusionsvätska, lösning
A medicinal product containing ifosfamide, registered in Sweden by Baxter Medical AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Ifosfamide
- Manufacturer
- Baxter Medical AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20250227000046
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ifosfamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaHOLOXANBaxter Oncology GmbH, Halle
- FinlandHoloxanBaxter Oy
- IcelandHoloxanBaxter Medical AB*
- NorwayHoloxanBaxter Medical AB
- United StatesIFEXBaxter Healthcare Corporation
- United KingdomIfosfamide 1g powder for concentrate for solution for injection vialsAlliance Healthcare (Distribution) Ltd
- BelgiumHoloxan 1 gBaxter
- GermanyHoloxanBaxter Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Holoxan
- Belgium · Holoxan
- Bulgaria · Холоксан
- Czechia · Holoxan
- Germany · Holoxan, Ifo-Cell
- Denmark · Holoxan
- Estonia · Holoxan
- Spain · Tronoxal
- Finland · Holoxan
- France · Holoxan, Ifosfamide Eg
- United Kingdom (Northern Ireland) · Ifosfamide Baxter Healthcare
- Greece · Holoxan
- Croatia · Holoxan
- Hungary · Holoxan
- Ireland · Mitoxana
- Iceland · Holoxan
- Italy · Holoxan
- Lithuania · Holoxan
- Luxembourg · Holoxan
- Latvia · Holoxan
- Malta · Mitoxana
- Netherlands · Holoxan
- Norway · Holoxan
- Poland · Holoxan
- Portugal · Holoxan
- Romania · Holoxan
- Slovenia · Holoxan
- Slovakia · Holoxan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66235439-e818-408b-9199-46f988a7d0c3 GET /v1/drugs/66235439-e818-408b-9199-46f988a7d0c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC"
],
"se_npl_id": "20250227000046",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20250227000046",
"product_doc_link": "https://docetp.mpa.se/LMF/Holoxan%20500%20mg%2C%201000%20mg%2C%202000%20mg%20powder%20for%20solution%20for%20injection_infusion%20SmPC_09001bee8484978d.pdf"
}See everything about ifosfamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.